ZA995321B - Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them. - Google Patents
Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them.Info
- Publication number
- ZA995321B ZA995321B ZA9905321A ZA995321A ZA995321B ZA 995321 B ZA995321 B ZA 995321B ZA 9905321 A ZA9905321 A ZA 9905321A ZA 995321 A ZA995321 A ZA 995321A ZA 995321 B ZA995321 B ZA 995321B
- Authority
- ZA
- South Africa
- Prior art keywords
- alkyl
- indan
- compounds
- preparation
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9810601A FR2782515B1 (fr) | 1998-08-21 | 1998-08-21 | NOUVEAUX DERIVES DE L'INDANE-1-Ol, LEUR PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LES CONTIENNENT |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA995321B true ZA995321B (en) | 2000-02-22 |
Family
ID=9529811
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9905321A ZA995321B (en) | 1998-08-21 | 1999-08-20 | Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them. |
Country Status (19)
Country | Link |
---|---|
US (1) | US6153625A (xx) |
EP (1) | EP0982305B1 (xx) |
JP (1) | JP2000072748A (xx) |
CN (1) | CN1128144C (xx) |
AT (1) | ATE214064T1 (xx) |
AU (1) | AU747494B2 (xx) |
BR (1) | BR9903867A (xx) |
CA (1) | CA2280596A1 (xx) |
DE (1) | DE69900961T2 (xx) |
DK (1) | DK0982305T3 (xx) |
ES (1) | ES2172294T3 (xx) |
FR (1) | FR2782515B1 (xx) |
HK (1) | HK1026212A1 (xx) |
HU (1) | HUP9902784A3 (xx) |
NO (1) | NO317516B1 (xx) |
NZ (1) | NZ337362A (xx) |
PL (1) | PL194852B1 (xx) |
PT (1) | PT982305E (xx) |
ZA (1) | ZA995321B (xx) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR0206514A (pt) * | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composto, método de tratamento de um ser humano ou animal que sofre de enxaqueca, uso do composto, composição farmacêutica, e, processo para preparar um composto |
BR0206513A (pt) * | 2001-01-16 | 2004-01-06 | Astrazeneca Ab | Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos |
WO2002055012A2 (en) * | 2001-01-16 | 2002-07-18 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
SE0103646D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic chroman compounds |
SE0103647D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic chromone compounds |
DE10142662B4 (de) * | 2001-08-31 | 2004-07-08 | Aventis Pharma Deutschland Gmbh | Derivate von C2-substituierten Indan-1-ol-Systemen und ihre Verwendung als Arzneimittel |
DE10142667B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
DE10142661B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | Mehrfach substituierte Indan-1-ol-Systeme und ihre Verwendung als Arzneimittel |
UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
CN116283657B (zh) * | 2023-02-22 | 2024-08-20 | 贵州大学 | 一种茚酮衍生物及其合成方法和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2681325B1 (fr) * | 1991-09-16 | 1993-12-17 | Fabre Medicament Pierre | Derives de l'aminomethyl-4 piperidine, leur preparation et leur application en therapeutique. |
GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
FR2761358B1 (fr) * | 1997-03-27 | 1999-05-07 | Adir | Nouveaux composes de n-aryl piperidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-08-21 FR FR9810601A patent/FR2782515B1/fr not_active Expired - Fee Related
-
1999
- 1999-08-13 US US09/374,161 patent/US6153625A/en not_active Expired - Fee Related
- 1999-08-19 HU HU9902784A patent/HUP9902784A3/hu unknown
- 1999-08-19 JP JP11232097A patent/JP2000072748A/ja active Pending
- 1999-08-20 PT PT99402092T patent/PT982305E/pt unknown
- 1999-08-20 NZ NZ337362A patent/NZ337362A/xx unknown
- 1999-08-20 DE DE69900961T patent/DE69900961T2/de not_active Expired - Fee Related
- 1999-08-20 AU AU44637/99A patent/AU747494B2/en not_active Ceased
- 1999-08-20 EP EP99402092A patent/EP0982305B1/fr not_active Expired - Lifetime
- 1999-08-20 CN CN99119425A patent/CN1128144C/zh not_active Expired - Fee Related
- 1999-08-20 BR BR9903867-6A patent/BR9903867A/pt not_active Application Discontinuation
- 1999-08-20 PL PL335012A patent/PL194852B1/pl not_active IP Right Cessation
- 1999-08-20 AT AT99402092T patent/ATE214064T1/de not_active IP Right Cessation
- 1999-08-20 NO NO19994041A patent/NO317516B1/no unknown
- 1999-08-20 ES ES99402092T patent/ES2172294T3/es not_active Expired - Lifetime
- 1999-08-20 ZA ZA9905321A patent/ZA995321B/xx unknown
- 1999-08-20 CA CA002280596A patent/CA2280596A1/fr not_active Abandoned
- 1999-08-20 DK DK99402092T patent/DK0982305T3/da active
-
2000
- 2000-09-04 HK HK00105538A patent/HK1026212A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU747494B2 (en) | 2002-05-16 |
PL335012A1 (en) | 2000-02-28 |
PT982305E (pt) | 2002-07-31 |
HU9902784D0 (en) | 1999-10-28 |
JP2000072748A (ja) | 2000-03-07 |
NO994041D0 (no) | 1999-08-20 |
CN1250051A (zh) | 2000-04-12 |
FR2782515B1 (fr) | 2000-09-22 |
CN1128144C (zh) | 2003-11-19 |
NO994041L (no) | 2000-02-22 |
NZ337362A (en) | 2000-04-28 |
ATE214064T1 (de) | 2002-03-15 |
BR9903867A (pt) | 2000-09-05 |
HK1026212A1 (en) | 2000-12-08 |
FR2782515A1 (fr) | 2000-02-25 |
ES2172294T3 (es) | 2002-09-16 |
AU4463799A (en) | 2000-03-09 |
HUP9902784A2 (hu) | 2000-12-28 |
HUP9902784A3 (en) | 2001-03-28 |
NO317516B1 (no) | 2004-11-08 |
US6153625A (en) | 2000-11-28 |
EP0982305A1 (fr) | 2000-03-01 |
PL194852B1 (pl) | 2007-07-31 |
DE69900961T2 (de) | 2002-11-07 |
DK0982305T3 (da) | 2002-06-24 |
CA2280596A1 (fr) | 2000-02-21 |
EP0982305B1 (fr) | 2002-03-06 |
DE69900961D1 (de) | 2002-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9903998D0 (sv) | New compounds | |
NZ505453A (en) | Hypolipidemic benzothiazepine compounds | |
ATE296826T1 (de) | Pyrazolo(1,5)pyridinderivate | |
DE60112609D1 (en) | Pyrazolopyridine | |
PT1263725E (pt) | Novos compostos | |
CO5180642A1 (es) | Compuestos sustituidos de piperidina, procesos para su prepa racion, composiciones farmaceuticas que los contienen y su utilizacion | |
TR200001973T2 (tr) | 11 ß-halojen-7alfa-ile ikame edilmiş-estratrienler, bu 11ß-halojen-7alfa-ile ikame edilmiş-estratrienleri içeren farmasötik terkiplerin üretimi için yöntem ve ilaç üretiminde kullanımları. | |
HUP0301422A2 (hu) | Ösztrogén hatású szereket tartalmazó gyógyászati készítmények | |
ATE316083T1 (de) | Adamantanderivate | |
HUP0400250A2 (hu) | 5-HT6 és/vagy 5-HT7 szerotonin receptorok ligandumaként alkalmazott 5-halogén-triptamin-származékok, előállításuk és alkalmazásuk gyógyszerkészítmények előállítására | |
ATE300541T1 (de) | Pyrazolopyridinderivate | |
SE9903997D0 (sv) | New compounds | |
DE60001586D1 (de) | Diphenyl-piperidin derivate | |
ZA995321B (en) | Indan-1-Ol compounds, a process for their preparation and pharmaceutical compositions containing them. | |
DE69933885D1 (de) | Triphenylbutenderivate zur behandlung von neurologischen störungen | |
HUP9902199A1 (hu) | Új nitronszármazékok, ezek előállítási eljárása és ezeket tartalmazó gyógyszerkészítmények | |
DE60201074D1 (en) | Pyrazolopyridinderivate | |
MXPA05010783A (es) | Derivados antimicrobianos de [3.1.0] biciclohexilfenil-oxazolidinona y analogos. | |
AU2002357740A1 (en) | Pyrazolo-pyridine derivatives as antiherpes agents | |
BG105923A (en) | Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives | |
SE9903996D0 (sv) | New compounds | |
IL70557A (en) | 4-(1-phenyl-1-hydroxypropyl)-resorcin derivatives,their preparation and pharmaceutical compositions containing them | |
HK1024244A1 (en) | 8h-thieno-(2,3-b)pyrrolizin-8-one compounds, a process for their preir preparation and pharmaceutical compositions containing them | |
HUP9801451A2 (hu) | Tetrahidroimidazo[2,1-a]izokinolin-származékok és ezeket tartalmazó gyógyszerkészítmények, alkalmazásuk | |
EE200200302A (et) | Küllastumata 14,15-tsüklopropanoandrostaanid, nende valmistamise meetod ja neid ühendeid sisaldavadfarmatseutilised kompositsioonid |